Literature DB >> 17307506

Axillary versus femoral cannulation for aortic surgery: enough evidence for a general recommendation?

Helmut Gulbins1, Anita Pritisanac, Jürgen Ennker.   

Abstract

There is a trend towards cannulation of the axillary artery for extracorporeal circulation in patients requiring aortic arch surgery. We analyzed the published data comparing axillary and femoral cannulation for safety and outcome. End points were death; stroke, neurologic, and vascular complications; and malperfusion. Femoral cannulation is safe for extracorporeal circulation in patients without aortic arch surgery. In patients with type A dissections, malperfusion may occur owing to retrograde perfusion of the false lumen and subsequent occlusion of the origin of the supra aortic vessels. Cannulation of the axillary/subclavian artery results in antegrade flow, at least in the right carotid artery, with the possibility of antegrade cerebral perfusion during aortic arch repair. There was a trend towards improved neurologic outcome when the axillary artery was used for extracorporeal circulation in such patients. When different techniques were compared, the use of a side graft for axillary cannulation reduced the complication rate. The lack of randomized trials and the high variety of inclusion criteria in the different studies do not allow a general recommendation for the use of the axillary artery as cannulation site.

Entities:  

Mesh:

Year:  2007        PMID: 17307506     DOI: 10.1016/j.athoracsur.2006.10.068

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  20 in total

1.  "Branch-first" continuous perfusion aortic arch replacement and its role in intra-operative cerebral protection.

Authors:  George Matalanis; Sean D Galvin
Journal:  Ann Cardiothorac Surg       Date:  2013-03

2.  Consensus on hypothermia in aortic arch surgery.

Authors:  Tristan D Yan; Paul G Bannon; Joseph Bavaria; Joseph S Coselli; John A Elefteriades; Randall B Griepp; G Chad Hughes; Scott A LeMaire; Teruhisa Kazui; Nicholas T Kouchoukos; Martin Misfeld; Friedrich W Mohr; Aung Oo; Lars G Svensson; David H Tian
Journal:  Ann Cardiothorac Surg       Date:  2013-03

Review 3.  Managing dissections of the thoracic aorta.

Authors:  Daniel R Wong; Scott A Lemaire; Joseph S Coselli
Journal:  Am Surg       Date:  2008-05       Impact factor: 0.688

4.  Treatment of malperfusion during surgery for type A aortic dissection.

Authors:  Salvatore Lentini; Marcello Savasta; Francesco Ciuffreda; Marco La Monaca; Roberto Gaeta
Journal:  J Extra Corpor Technol       Date:  2009-06

5.  Cannulation strategies for aortic surgery: which is the best one?

Authors:  Shahzad G Raja
Journal:  J Thorac Dis       Date:  2017-05       Impact factor: 2.895

Review 6.  Intraoperative care for aortic surgery using circulatory arrest.

Authors:  Félix Ezequiel Fernández Suárez; David Fernández Del Valle; Adrián González Alvarez; Blanca Pérez-Lozano
Journal:  J Thorac Dis       Date:  2017-05       Impact factor: 2.895

7.  Axillary Versus Femoral Arterial Cannulation During Repair of Type A Aortic Dissection?: An Old Problem Seeking New Solutions.

Authors:  Sotiris C Stamou; Derek Gartner; Nicholas T Kouchoukos; Kevin W Lobdell; Kamal Khabbaz; Edward Murphy; Robert C Hagberg
Journal:  Aorta (Stamford)       Date:  2016-08-01

Review 8.  Cannulation strategies in aortic surgery: techniques and decision making.

Authors:  Shiv K Choudhary; Pradeep R Reddy
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2021-06-08

9.  Postoperative peri-axillary seroma following axillary artery cannulation for surgical treatment of acute type A aortic dissection.

Authors:  Efstratios E Apostolakis; Nikolaos G Baikoussis; Konstantinos Katsanos; Menelaos Karanikolas
Journal:  J Cardiothorac Surg       Date:  2010-05-25       Impact factor: 1.637

Review 10.  Shaggy and calcified aorta: surgical implications.

Authors:  Ikuo Fukuda; Kazuyuki Daitoku; Masahito Minakawa; Wakako Fukuda
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-02-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.